Not recruiting yet
Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules
NCT07545057 · Shanghai Chest Hospital · Updated 28 April 2026
- What is being tested
- Robotic-assisted bronchoscopy-guided synchronous biopsy and radiofrequency ablation for pulmonary nodules
- For
- Pulmonary Nodules
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 100 years. About 76 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 May 2026, ends 31 Dec 2027. Registered 22 April 2026.
- Results
- None posted yet.
In the researchers' words
This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.
Sites
- Shanghai Chest HospitalShanghai, China
